ABPA Clinical Trials

8 recruitingLast updated: July 25, 2026

There are 8 actively recruiting abpa clinical trials across 1 country. Top locations include Jinan, Shandong, China, Ningbo, Zhejiang, China. Updated daily from ClinicalTrials.gov.


ABPA Trials at a Glance

8 actively recruiting trials for abpa are listed on ClinicalTrialsFinder across 2 cities. Lead sponsors running abpa studies include Qianfoshan Hospital and First Affiliated Hospital of Ningbo University.

About ABPA Clinical Trials

Looking for clinical trials for ABPA? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ABPA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ABPA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Fungal Status and Prognosis in ABPA

Allergic Bronchopulmonary AspergillosisABPAAllergic Bronchopulmonary Aspergillosis (ABPA)+1 more
Qianfoshan Hospital114 enrolled1 locationNCT07690345
Recruiting

Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction

RelapseMulticenter StudyMulti-omics+2 more
Qianfoshan Hospital300 enrolled1 locationNCT07611838
Recruiting

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary AspergillosisSevere AsthmaABPA
Qianfoshan Hospital20 enrolled2 locationsNCT07530770
Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting

Immune Status and Disease Control of Inflammatory Airway Diseases

Airway inflammationChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis+3 more
First Affiliated Hospital of Ningbo University200 enrolled1 locationNCT07493629
Recruiting

A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA

Airway ClearanceAllergic Bronchopulmonary AspergillosisABPA+4 more
Qianfoshan Hospital44 enrolled1 locationNCT07362667
Recruiting

Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis

AsthmaBronchiectasisEnvironmental Exposure+1 more
First Affiliated Hospital of Ningbo University125 enrolled1 locationNCT07313904
Recruiting

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis (ABPA)
Qianfoshan Hospital140 enrolled1 locationNCT07040332